Genus plc is a United Kingdom-based animal protein genetics company. The Company supplies breeding animals with desirable characteristics for farmers, enabling them to produce quality meat and milk. Its segments include Genus PIC, Genus ABS and Genus Research and Development. The Genus PIC segment is engaged in the porcine sales business. The Genus ABS segment is engaged in the bovine sales business. Its bovine genetics business sells dairy and beef bull semen and embryos from its superior cattle, which are sold to farmers to breed their cows through artificial insemination. Its porcine genetics business sells genetically superior breeding pigs and semen to farmers, so they can breed commercial pigs with desirable characteristics for pork production. It also provides technical services and advice to farmers, to maximize the performance of its breeding animals in their farms. The Company has supply chain and distribution networks in over 80 countries.
Biotechnology & Drugs
Basingstoke, United Kingdom
What the Analysts think about Genus
Majority rating from 7 analysts.
Average projection from 7 analysts.
Average price target
Genus Financial Performance
Income StatementBalance sheetCash Flow
4.04% profit margin
Revenues and expenses
Genus Earnings Performance
No data availble
Quarterly data is not available. You can look at the annual data instead.
Earnings per share (EPS)
Latest price is delayed by 15 minutes. Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by ICE Data Services and LSEG. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Buy or sell Genus stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.